Newsletter | November 29, 2022

11.29.22 -- De-Risking Your Bioconjugate's Development Path From Discovery To The Clinic

Industry Insights
De-Risking Your Bioconjugate’s Development Path From Discovery To The Clinic

Understanding the obstacles you may face during bioconjugate development, as well as the tools available to help overcome them, can help streamline your product’s path to market.

Transforming Supply Chain Risks Into A Competitive Advantage In The CRO-CDMO Space

Explore the typical supply chain challenges faced by global CROs and CDMOs and how one company has transformed its supply chain to mitigate these risks and turn them into a competitive advantage.

Simultaneous Spray Drying For Combination Dry Powder Inhaler Formulations

Three combination case studies are demonstrated in which bevacizumab is paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.

"Ultra High” Potency Development And Manufacture

A biotech with limited experience in the development and manufacture of high potency compounds sought to develop a process for producing a highly potent API used to treat an unmet oncology need.

Pharmaceutical Spray Drying: Sustainable Commercial Best Practices To Continuous Project-Focused Innovation

Learn more about defining the spray-drying process with an emphasis on specific enhancements to accommodate scale-up to commercial-scale equipment of challenging applications or molecules.

Q&A: Discussing The Lab Of The 21st Century

Life sciences companies are turning to platform solutions with end-to-end capabilities, along with the underlying infrastructure and ability to implement industry standards. Learn why digital continuity is so important to succeed.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.